Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

A major change in the way HHS plans to evaluate vaccine safety is raising fears that approvals will become unnecessarily ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine is sowing uncertainty about other ...

More than 880 measles cases have been reported in the U.S. since February, including at least 660 in Texas, amid rising ...

Per the Post, which first reported the story, “‘All new vaccines will undergo safety testing in placebo-controlled trials ...

On a Thursday conference call with investors, Moderna CFO Jamey Mock outlined a roadmap for the mRNA specialist to lower its ...

The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

Novavax’s COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday. The update sent Nova ...

Several current and former FDA employees who spoke to Inside Medicine on the condition of anonymity have come to see the ...

According to the WSJ, the universal vaccine project is being pioneered by two recently appointed senior scientists in the NIH ...

Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...